Pharmaceutical Promotion to Physicians and First Amendment Rights

Legal restrictions on off-label drug promotion, which are being challenged as First Amendment violations, are justified because pharmaceutical promotion presents unique public health concerns that distinguish it from other commercial speech. Courts should permit more stringent regulation of pharmaceutical promotion despite First Amendment protections for commercial speech.